SKIP TO MAIN CONTENT

$1.2m grant for Vatican-backed stem cells

US stemcell research that has stirred controversy due to a marketing partnership with the Vatican has landed a $US1.2 million grant.

2 min read

Published

Updated

Source: AAP


Skip to article content

A Vatican-backed US company that researches an alternative to embryonic stem cells has received a $US1.2 million ($A1.30 million) dollar government grant, despite independent studies that question whether their product even exists.

NeoStem, a New Jersey-headquartered company, is investigating very small embryonic-like (VSEL) cells found in adult bone marrow that they say may be able to regrow into different kinds of tissue.

The research has stirred controversy due to NeoStem's marketing partnership with the Vatican and three independent studies that have been unable to confirm the cells are even there.

The latest peer-reviewed grant, totaling $US1,221,854, was provided by the US National Institutes of Health on Friday for research on an experimental drug that could regenerate bone tissue damaged by periodontitis, a serious gum disease.

The company, along with other partner institutions, has already received $US4.5 million in government research grants, including from the Department of Defense and the NIH.

News that makes sense

Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

"We are very excited about our progress towards the IND (investigational new drug) submission for what we expect to be the first human clinical study for our VSEL Technology and for the support of the NIH," said a statement by NeoStem chief executive Robin Smith.

In July, scientists at Stanford University said in the journal Stem Cell Reports they could not replicate NeoStem's findings of VSELs in the bone marrow of lab mice.

Instead, they found that what was purported to be VSELs were either debris or dead cells.

Two previous studies published in the journal PLoS One in 2012 and 2013 also described unsuccessful attempts to locate the cells.

The field of stem cell research has raised hopes of finding cures for everything from blindness to paralysis, but the work is controversial.

Embryonic stem cell research has been a political lightning rod, opposed by religious groups and individuals who find fault with destroying a human life form.


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world